🔗 Share this article

The top legal official in Texas Ken Paxton is suing the producers of Tylenol, asserting the companies withheld potential risks that the drug posed to children's neurological development.

The lawsuit arrives a month after President Donald Trump advocated an unproven link between taking acetaminophen - referred to as acetaminophen - during pregnancy and autism spectrum disorder in young ones.

The attorney general is taking legal action against the pharmaceutical giant, which previously sold the medication, the exclusive pain medication suggested for women during pregnancy, and Kenvue, which presently makes it.

In a official comment, he claimed they "betrayed America by profiting off of pain and promoting medication ignoring the risks."

The company states there is lacking scientific proof tying Tylenol to autism spectrum disorder.

"These corporations misled for generations, knowingly endangering numerous people to increase profits," the attorney general, a Republican, stated.

Kenvue stated officially that it was "seriously troubled by the spread of false claims on the security of acetaminophen and the possible consequences that could have on the well-being of American women and children."

On its online platform, the company also mentioned it had "consistently assessed the pertinent research and there is no credible data that indicates a established connection between consuming paracetamol and autism."

Groups representing doctors and medical practitioners share this view.

ACOG has said paracetamol - the main ingredient in Tylenol - is one of the few options for pregnant women to address pain and elevated temperature, which can present major wellness concerns if ignored.

"In more than two decades of research on the consumption of acetaminophen in pregnancy, no reliable research has definitively established that the usage of acetaminophen in any period of gestation leads to neurological conditions in offspring," the association commented.

The lawsuit references latest statements from the former administration in claiming the drug is allegedly unsafe.

Recently, Trump generated worry from health experts when he instructed expectant mothers to "resist strongly" not to consume Tylenol when unwell.

Federal regulators then released a statement that medical professionals should think about restricting the use of acetaminophen, while also stating that "a causal relationship" between the drug and autism in minors has not been proven.

The Health Department head Kennedy, who manages the Food and Drug Administration, had promised in spring to initiate "extensive scientific investigation" that would establish the origin of autism spectrum disorder in a short period.

But authorities warned that discovering a single cause of autism - believed by scientists to be the outcome of a complicated interplay of inherited and surrounding conditions - would prove challenging.

Autism spectrum disorder is a category of lifelong neurodivergence and impairment that affects how persons experience and relate to the world, and is identified using medical professional evaluations.

In his legal document, the attorney general - who supports Trump who is seeking federal office - asserts Kenvue and Johnson & Johnson "intentionally overlooked and sought to suppress the evidence" around paracetamol and autism.

The lawsuit aims to force the corporations "remove any commercial messaging" that claims acetaminophen is secure for pregnant women.

This legal action parallels the complaints of a group of mothers and fathers of minors with autism and attention deficit hyperactivity disorder who took legal action against the producers of acetaminophen in two years ago.

A federal judge dismissed the case, declaring investigations from the family's specialists was lacking definitive proof.